Accuracy and feasibility of initiating real-time continuous glucose monitoring in noncritically ill hospitalized patients with type 2 diabetes
Genauigkeit und Machbarkeit der Einleitung eines Echtzeit-Continuous-Glucose-Monitorings bei nicht kritisch kranken hospitalisierten Patient:innen mit Typ-2-Diabetes
World Journal of Diabetes · 15.11.2026 · 17 (11)
DOI: 10.4239/wjd.124291 ↗Auf einen Blick
Bei 25 stationären Patient:innen mit Typ-2-Diabetes war der Einsatz von Glunovo i3 rt-CGM über 7,7 Tage machbar und zeigte eine akzeptable Genauigkeit.
Fragestellung
Wie genau und machbar ist die Einleitung von Glunovo i3 rt-CGM bei nicht kritisch kranken stationären Patient:innen mit Typ-2-Diabetes?
Methode
25 Patient:innen mit Typ-2-Diabetes; Glunovo i3 rt-CGM am Abdomen; Kalibrierung mit kapillären Blutzuckerwerten; Auswertung von MARD und Clarke Error Grid Analysis.
Ergebnisse
397 gepaarte Messungen. Gesamt-MARD 12,2 % ± 12,2 %; bei CBG > 180 mg/dL 11,0 % ± 11,1 %. 96,7 % der Werte lagen in CEGA-Zone A/B; keine in Zone E.
Schlussfolgerung der Autor:innen
Der Beginn des Glunovo i3 rt-CGM-Systems bei nicht kritisch kranken hospitalisierten Patient:innen mit insulinbehandeltem T2DM ist machbar und zeigt während des Aufenthalts eine akzeptable Genauigkeit und Sicherheit.
Kernaussagen
- 25 stationäre Patient:innen mit T2DM
- Gesamt-MARD 12,2 % ± 12,2 %
- 96,7 % der Messpunkte in CEGA-Zone A/B
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 15.11.2026. Verfasst von Sirinart Sirinvaravong und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND Continued use of personal continuous glucose monitoring (CGM) devices is recommended for people with diabetes receiving insulin therapy during hospitalization to achieve better glycemic control and reduce hypoglycemia. However, data on the initiation of real-time CGM (rt-CGM) in hospitalized patients remain limited. AIM To evaluate accuracy and feasibility of initiating Glunovo i3 rt-CGM for general-medicine inpatients with type 2 diabetes mellitus (T2DM). METHODS A total of 25 patients with T2DM were enrolled. The mean age was 72.8 ± 11.6 years, 64% were female, and the mean glycated hemoglobin was 10.0% ± 3.1%. The Glunovo i3 rt-CGM sensor and transmitter were placed on the patient’s abdomen. Medical personnel calibrated the device using capillary blood glucose (CBG) measurements. Paired CBG and sensor glucose values were analyzed to assess the accuracy of CGM using the mean absolute relative difference (MARD) and Clarke Error Grid Analysis (CEGA). RESULTS CGM was used for 7.7 ± 2.4 days, with calibration performed 2.3 ± 0.7 times/day. Among 397 paired CBG and CGM measurements, overall MARD was 12.2% ± 12.2%, with the lowest MARD observed at CBG levels > 180 mg/dL (11.0% ± 11.1%). The percentages of readings within ± 15%/15 mg/dL, ± 20%/20 mg/dL, and ± 30%/30 mg/dL were 72.8%, 82.9%, and 91.7%, respectively. Overall, 96.7% of points fell within CEGA zones A and B, with none in zone E. Time in range improved from 41.2% ± 26.2% on day 1 to 48.3% ± 22.3% during the last 72 hours (P = 0.469). CONCLUSION Initiation of the Glunovo i3 rt-CGM system in noncritically ill hospitalized patients with insulin-treated T2DM is feasible and demonstrates acceptable accuracy and safety for glucose monitoring during hospitalization.
Zitieren
APA
Sirinvaravong, S., Sakjirapapong, C., Preechasuk, L., & Thongtang, N. (2026). Accuracy and feasibility of initiating real-time continuous glucose monitoring in noncritically ill hospitalized patients with type 2 diabetes. World Journal of Diabetes, 17(11). https://doi.org/10.4239/wjd.124291
Vancouver
Sirinvaravong S, Sakjirapapong C, Preechasuk L, Thongtang N. Accuracy and feasibility of initiating real-time continuous glucose monitoring in noncritically ill hospitalized patients with type 2 diabetes. World Journal of Diabetes. 2026;17(11). doi:10.4239/wjd.124291
BibTeX
@article{Sirinvaravong2026,
author = {Sirinvaravong, Sirinart and Sakjirapapong, Choompunuj and Preechasuk, Lukana and Thongtang, Nuntakorn},
title = {Accuracy and feasibility of initiating real-time continuous glucose monitoring in noncritically ill hospitalized patients with type 2 diabetes},
journal = {World Journal of Diabetes},
year = {2026},
volume = {17},
number = {11},
doi = {10.4239/wjd.124291}
}
EUVIMED